Zeineb Hachicha1, Jean G Dumesnil, Philippe Pibarot. 1. Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Department of Medicine, Laval University, Québec City, Québec G1V 4G5, Canada.
Abstract
OBJECTIVES: This study was designed to examine the prognostic value of valvuloarterial impedance (Z(va)) in patients with aortic stenosis (AS). BACKGROUND: We previously showed that the Z(va) is superior to standard indexes of AS severity in estimating the global hemodynamic load faced by the left ventricle (LV) and predicting the occurrence of LV dysfunction. This index is calculated by dividing the estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the stroke volume indexed for the body surface area. METHODS: We retrospectively analyzed the clinical and echocardiographic data of 544 consecutive patients having at least moderate AS (aortic jet velocity > or =2.5 m.s(-1)) and no symptoms at baseline. The primary end point for this study was the overall mortality regardless of the realization of aortic valve replacement (AVR). RESULTS: Four-year survival was significantly (p < 0.001) lower in the patients with a baseline Z(va) > or =4.5 mm Hg x ml(-1) x m(2) (65 +/- 5%) compared with those with Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) (78 +/- 4%) and those with Z(va) < or =3.5 mm Hg x ml(-1) x m(2) (88 +/- 3%). The risk of mortality was increased by 2.76-fold in patients with Z(va) > or =4.5 mm Hg x ml(-1) x m(2) and by 2.30-fold in those with a Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) after adjusting for other risk factors and type of treatment (surgical vs. medical). CONCLUSIONS: Increased Z(va) is a marker of excessive LV hemodynamic load, and a value >3.5 successfully identifies patients with a poor outcome. These findings suggest that beyond standard indexes of stenosis severity, the consideration of Z(va) may be useful to improve risk stratification and clinical decision making in patients with AS.
OBJECTIVES: This study was designed to examine the prognostic value of valvuloarterial impedance (Z(va)) in patients with aortic stenosis (AS). BACKGROUND: We previously showed that the Z(va) is superior to standard indexes of AS severity in estimating the global hemodynamic load faced by the left ventricle (LV) and predicting the occurrence of LV dysfunction. This index is calculated by dividing the estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the stroke volume indexed for the body surface area. METHODS: We retrospectively analyzed the clinical and echocardiographic data of 544 consecutive patients having at least moderate AS (aortic jet velocity > or =2.5 m.s(-1)) and no symptoms at baseline. The primary end point for this study was the overall mortality regardless of the realization of aortic valve replacement (AVR). RESULTS: Four-year survival was significantly (p < 0.001) lower in the patients with a baseline Z(va) > or =4.5 mm Hg x ml(-1) x m(2) (65 +/- 5%) compared with those with Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) (78 +/- 4%) and those with Z(va) < or =3.5 mm Hg x ml(-1) x m(2) (88 +/- 3%). The risk of mortality was increased by 2.76-fold in patients with Z(va) > or =4.5 mm Hg x ml(-1) x m(2) and by 2.30-fold in those with a Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) after adjusting for other risk factors and type of treatment (surgical vs. medical). CONCLUSIONS: Increased Z(va) is a marker of excessive LV hemodynamic load, and a value >3.5 successfully identifies patients with a poor outcome. These findings suggest that beyond standard indexes of stenosis severity, the consideration of Z(va) may be useful to improve risk stratification and clinical decision making in patients with AS.
Authors: Yukari Kobayashi; Juyong B Kim; Kegan J Moneghetti; Yuhei Kobayashi; Ran Zhang; Daniel A Brenner; Ryan O'Malley; Ingela Schnittger; Michael Fischbein; D Craig Miller; Alan C Yeung; David Liang; Francois Haddad; William F Fearon Journal: Int J Cardiovasc Imaging Date: 2017-05-17 Impact factor: 2.357
Authors: Brian R Lindman; Alan Zajarias; José A Madrazo; Jay Shah; Brian F Gage; Eric Novak; Stephanie N Johnson; Murali M Chakinala; Tara A Hohn; Mohammed Saghir; Douglas L Mann Journal: Circulation Date: 2012-03-25 Impact factor: 29.690
Authors: Mackram F Eleid; Paul Sorajja; Hector I Michelena; Joseph F Malouf; Christopher G Scott; Patricia A Pellikka Journal: Circulation Date: 2013-09-18 Impact factor: 29.690
Authors: E Mara Vollema; Tadafumi Sugimoto; Mylène Shen; Lionel Tastet; Arnold C T Ng; Rachid Abou; Nina Ajmone Marsan; Bart Mertens; Raluca Dulgheru; Patrizio Lancellotti; Marie-Annick Clavel; Philippe Pibarot; Philippe Genereux; Martin B Leon; Victoria Delgado; Jeroen J Bax Journal: JAMA Cardiol Date: 2018-09-01 Impact factor: 14.676